Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neel Dhudshia

Thoracic Surgery (Cardiothoracic Vascular Surgery) Henderson, NV Medical Doctor

NPI 1811975642 CMS profile 82418

10001 S Eastern Ave Ste 201, Henderson, NV 89052

Open in the dashboard

General payments

$65,523

721 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Neel Dhudshia of Henderson, NV is reported in the CMS Open Payments database as having received $65,523 across 721 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,897 106
2024 General $18,605 112
2023 General $8,519 108
2022 General $16,064 122
2021 General $3,120 69
2020 General $4,430 89
2019 General $4,888 115

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neel Dhudshia
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Neel Dhudshia were reported at $9,897. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Neel Dhudshia Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,888 $886 $178–$3,167 $163
2020 $4,430 $341 $108–$1,605 $114
2021 $3,120 $453 $125–$1,886 $132
2022 $16,064 $695 $180–$2,566 $149
2023 $8,519 $745 $205–$2,662 $160
2024 $18,605 $799 $214–$2,967 $164
2025 $9,897 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bolton Medical Inc $43,910 263 payments
  2. Medtronic, Inc. $6,449 151 payments
  3. W. L. Gore & Associates, Inc. $4,661 107 payments
  4. Medtronic Vascular, Inc. $2,907 69 payments
  5. Abbott Laboratories $1,799 22 payments
  6. Abiomed $1,653 45 payments
  7. Medistim USA, Inc. $973 4 payments
  8. Atricure, Inc. $481 10 payments
  9. Teleflex LLC $421 4 payments
  10. Edwards Lifesciences Corporation $329 12 payments
  11. Other $1,941 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $30,210 691 payments
  2. Consulting Fee $21,325 13 payments
  3. Education $12,000 8 payments
  4. Travel and Lodging $1,989 9 payments
Products named General payments · program years 2019–2025
  1. TREO ABDOMINAL STENT-GRAFT SYSTEM $22,312 64 payments
  2. Grafts $13,601 58 payments
  3. RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM $6,803 113 payments
  4. COREVALVE EVOLUT R $3,277 63 payments
  5. EXCLUDER AAA Endoprosthesis $2,005 57 payments
  6. Impella $1,653 45 payments
  7. CoreValve Evolut $1,644 16 payments
  8. TAG Thoracic Endoprosthesis $1,608 27 payments
  9. Avalus $1,585 50 payments
  10. CG Future $952 51 payments
  11. Other $10,550 183 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$189,700

Medicare's payments for the services billed

Medicare patients

229

Average age 77

Services billed

600

85 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 72%
Diabetes 48%
Heart failure 46%
Atrial fibrillation 45%
Arthritis 45%
Chronic kidney disease 44%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

721 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record